Baldicantos, Janet .
HRN: 23-50-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/23/2023
METRONIDAZOLE 500MG (TAB)
12/23/2023
12/30/2023
PO
1 Tab
TID
SP NSVD MSAF Thickly
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes